Publications by authors named "Lucy Yan"

Claim this Profile
D
Design and validation of a rapid visual processing measure for screening reading difficulties in early childhood.
Mahalakshmi Ramamurthy, Klint Kanopka, Adam Richie-Halford, Benjamin W Domingue, Francesca Pei, Lucy Yan

Behav Res Methods· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis.
Winnie Sohn, Isidro B Salusky, Claus Peter Schmitt, Christina Taylan, Johan Vande Walle, Lucy Yan

Pediatr Nephrol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granger Causality of the Electroencephalogram Reveals Abrupt Global Loss of Cortical Information Flow during Propofol-induced Loss of Responsiveness.
Rebecca M Pullon, Lucy Yan, Jamie W Sleigh, Catherine E Warnaby

Anesthesiology· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-cost, microcontroller-based, two-channel piezoelectric bender device for somatosensory experiments.
Lucy Yan, Luke E Hallum

Annu Int Conf IEEE Eng Med Biol Soc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
Winnie Y Sohn, Anthony A Portale, Isidro B Salusky, Hao Zhang, Lucy L Yan

Pediatr Nephrol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
Winnie Y Sohn, Anthony A Portale, Isidro B Salusky, Hao Zhang, Lucy L Yan

Pediatr Nephrol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I, Randomized, Double-blind, Placebo-controlled, Single-dose, and Multiple-dose Studies of Erenumab in Healthy Subjects and Patients With Migraine.
Jan de Hoon, Anne Van Hecken, Corinne Vandermeulen, Lucy Yan, Brian Smith

Clin Pharmacol Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects.
Thuy Vu, Peiming Ma, Jiyun Sunny Chen, Jan de Hoon, Anne Van Hecken, Lucy Yan

Pharm Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjects.
Rameshraja Palaparthy, Christopher Banfield, Paco Alvarez, Lucy Yan, Brian Smith

Int J Clin Pharmacol Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors.
Michael S Gordon, Christopher S Sweeney, David S Mendelson, S Gail Eckhardt, Abraham Anderson, Lucy Yan

Clin Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors.
Patricia Lorusso, Elisabeth I Heath, Jesse McGreivy, Yu-Nien Sun, Rebeca Melara, Lucy Yan

Invest New Drugs· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis